Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
Erectile dysfunction (ED) is a prevalent form of male sexual dysfunction. Phosphodiesterase type 5 (PDE5) inhibitor is the first-line treatment for ED. Numerous well-designed and -conducted clinical trials and postmarketing studies have established the safety and efficacy of PDE5 inhibitors for the...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health/LWW
2016-06-01
|
| Serier: | Urological Science |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S187952261630029X |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|